JP2011500598A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500598A5
JP2011500598A5 JP2010529091A JP2010529091A JP2011500598A5 JP 2011500598 A5 JP2011500598 A5 JP 2011500598A5 JP 2010529091 A JP2010529091 A JP 2010529091A JP 2010529091 A JP2010529091 A JP 2010529091A JP 2011500598 A5 JP2011500598 A5 JP 2011500598A5
Authority
JP
Japan
Prior art keywords
pain
ring
aliphatic
cor
membered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010529091A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500598A (ja
JP5555169B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/079542 external-priority patent/WO2009049180A2/en
Publication of JP2011500598A publication Critical patent/JP2011500598A/ja
Publication of JP2011500598A5 publication Critical patent/JP2011500598A5/ja
Application granted granted Critical
Publication of JP5555169B2 publication Critical patent/JP5555169B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010529091A 2007-10-11 2008-10-10 電位開口型ナトリウムチャネルの阻害剤として有用なヘテロアリールアミド Expired - Fee Related JP5555169B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97925807P 2007-10-11 2007-10-11
US60/979,258 2007-10-11
PCT/US2008/079542 WO2009049180A2 (en) 2007-10-11 2008-10-10 Heteroaryl amides useful as inhibitors of voltage-gated sodium channels

Publications (3)

Publication Number Publication Date
JP2011500598A JP2011500598A (ja) 2011-01-06
JP2011500598A5 true JP2011500598A5 (https=) 2012-11-15
JP5555169B2 JP5555169B2 (ja) 2014-07-23

Family

ID=40429979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010529091A Expired - Fee Related JP5555169B2 (ja) 2007-10-11 2008-10-10 電位開口型ナトリウムチャネルの阻害剤として有用なヘテロアリールアミド

Country Status (9)

Country Link
US (1) US8519137B2 (https=)
EP (1) EP2227453B1 (https=)
JP (1) JP5555169B2 (https=)
CN (1) CN101883760A (https=)
AU (1) AU2008310660A1 (https=)
CA (1) CA2701946A1 (https=)
MX (1) MX2010003866A (https=)
NZ (1) NZ584475A (https=)
WO (1) WO2009049180A2 (https=)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5855095B2 (ja) 2010-06-07 2016-02-09 ノボメディックス, エルエルシーNovomedix, Llc フラニル化合物およびその使用
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US9212209B2 (en) 2012-07-13 2015-12-15 Indiana University Research And Technology Corporation Screening methods for spinal muscular atrophy
CA2898653C (en) 2013-01-31 2021-09-28 Vertex Pharmaceuticals Incorporated Amides as modulators of sodium channels
RU2683788C2 (ru) 2013-01-31 2019-04-02 Вертекс Фармасьютикалз Инкорпорейтед Амиды хинолина и хиназолина, полезные в качестве модуляторов натриевых каналов
RS56015B1 (sr) 2013-01-31 2017-09-29 Vertex Pharma Piridon amidi kao modulatori natrijumovih kanala
UA119147C2 (uk) 2013-07-19 2019-05-10 Вертекс Фармасьютікалз Інкорпорейтед Сульфонаміди як модулятори натрієвих каналів
CA2931550C (en) 2013-12-13 2023-09-26 Vertex Pharmaceuticals Incorporated Prodrugs of pyridone amides useful as modulators of sodium channels
JP2017538676A (ja) 2014-11-05 2017-12-28 ザ ユニバーシティ オブ カンザス ミトコンドリア透過性遷移孔(mtPTP)の小分子阻害剤
JP6930916B2 (ja) * 2015-02-12 2021-09-01 ユニヴァーシティ オブ サザン カリフォルニアUniversity of Southern California 疾患予防および治療における成長ホルモン受容体の遮断剤
EP3625214B1 (en) 2017-05-16 2022-07-06 Vertex Pharmaceuticals Incorporated Deuterated pyridone amides and prodrugs thereof as modulators of sodium channels
AU2018300150A1 (en) 2017-07-11 2020-01-30 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
CN108863970A (zh) 2017-08-14 2018-11-23 四川省中医药转化医学中心 新化合物及其在治疗炎症或炎症相关疾病方面的应用
US11529337B2 (en) 2018-02-12 2022-12-20 Vertex Pharmaceuticals Incorporated Method of treating pain
AU2019302534B2 (en) 2018-07-09 2024-10-03 Lieber Institute, Inc. Pyridazine compounds for inhibiting NaV1.8
CA3105657A1 (en) * 2018-07-09 2020-01-16 Lieber Institute, Inc. Pyridine carboxamide compounds for inhibiting nav1.8
MA53488A (fr) * 2018-08-31 2021-12-08 Xenon Pharmaceuticals Inc Composés de sulfonamide substitués par hétéroaryle et leur utilisation en tant qu'inhibiteurs de canaux sodiques
US12344595B2 (en) 2018-11-02 2025-07-01 Merck Sharp & Dohme Llc 2-amino-n-phenyl-nicotinamides as NAV1.8 inhibitors
JP7288051B2 (ja) 2018-11-02 2023-06-06 メルク・シャープ・アンド・ドーム・エルエルシー Nav1.8阻害薬としての2-アミノ-N-ヘテロアリール-ニコチンアミド類
WO2020146682A1 (en) 2019-01-10 2020-07-16 Vertex Pharmaceuticals Incorporated Carboxamides as modulators of sodium channels
US12440481B2 (en) 2019-01-10 2025-10-14 Vertex Pharmaceuticals Incorporated Esters and carbamates as modulators of sodium channels
WO2020199683A1 (zh) * 2019-04-04 2020-10-08 上海海雁医药科技有限公司 氮杂环取代的磺酰基苯甲酰胺衍生物、其制法与医药上的用途
CN112390745B (zh) * 2019-08-19 2022-10-21 江苏恒瑞医药股份有限公司 吡啶烟酰胺类衍生物、其制备方法及其在医药上的应用
BR112022010924A2 (pt) 2019-12-06 2022-09-06 Vertex Pharma Tetra-hidrofuranos substituídos como moduladores de canais de sódio
US11802122B2 (en) 2020-06-17 2023-10-31 Merck Sharp & Dohme Llc 2-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitors
US12516046B2 (en) 2020-06-17 2026-01-06 Merck Sharp & Dohme Llc 2-oxo-oxazolidine-5-carboxamides as NAV1.8 inhibitors
GEP20257795B (en) 2021-05-07 2025-09-25 Merck Sharp & Dohme Llc Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitors
SMT202500481T1 (it) 2021-06-04 2026-01-12 Vertex Pharma N-(idrossialchil(etero)aril)tetraidrofuran carbossammidi come modulatori di canali del sodio
TW202317520A (zh) 2021-06-15 2023-05-01 德商歌林達有限公司 經取代之吡唑醯胺
US20250154109A1 (en) * 2022-02-04 2025-05-15 Latigo Biotherapeutics, Inc Sodium channel blocking compounds, derivatives thereof, and methods of their use
CN116655497B (zh) * 2022-02-25 2025-06-03 中国科学院上海药物研究所 脒类衍生化合物及其制备方法和用途
CN116789644B (zh) * 2022-03-17 2025-11-11 中国科学院上海药物研究所 酰胺类化合物及其制备方法和用途
WO2023205463A1 (en) 2022-04-22 2023-10-26 Vertex Pharmaceuticals Incorporated Heteroaryl compounds for the treatment of pain
EP4385980A1 (en) 2022-12-14 2024-06-19 Grünenthal GmbH Indazoles as inhibitors of nav1.8
AR131345A1 (es) 2022-12-14 2025-03-12 Gruenenthal Gmbh SULFOXIMINAS COMO INHIBIDORES DE NaV1.8
EP4385979A1 (en) 2022-12-14 2024-06-19 Grünenthal GmbH Multicyclic inhibitors of nav1.8
EP4385984A1 (en) 2022-12-14 2024-06-19 Grünenthal GmbH Pyridine-n-oxides as inhibitors of nav1.8
CN119285621B (zh) * 2024-12-13 2025-07-18 嘉兴安帝康生物科技有限公司 作为钠通道调节剂的四氢呋喃甲酰胺类化合物及其在医药上的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE568114A (https=) * 1957-05-29 1900-01-01
ES482591A1 (es) * 1978-07-20 1980-04-01 Basf Ag Procedimiento para la obtencion de n-arilsulfonilpirroles.
US5304121A (en) 1990-12-28 1994-04-19 Boston Scientific Corporation Drug delivery system making use of a hydrogel polymer coating
US5886026A (en) 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
US6099562A (en) 1996-06-13 2000-08-08 Schneider (Usa) Inc. Drug coating with topcoat
HUP0103622A3 (en) * 1998-08-20 2003-01-28 Agouron Pharmaceuticals Inc La Non-peptide gnrh agents, methods and intermediates for their preparation and medicaments containing them
ATE299499T1 (de) * 1998-11-09 2005-07-15 Black James Foundation Gastrin und cholecystokinin rezeptor ligande
US6620849B2 (en) * 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6995162B2 (en) * 2001-01-12 2006-02-07 Amgen Inc. Substituted alkylamine derivatives and methods of use
US7105682B2 (en) 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
WO2003037274A2 (en) 2001-11-01 2003-05-08 Icagen, Inc. Pyrazole-amides and-sulfonamides
SE0203752D0 (sv) * 2002-12-17 2002-12-17 Astrazeneca Ab New compounds
WO2004106324A1 (en) * 2003-05-27 2004-12-09 E.I. Dupont De Nemours And Company Azolecarboxamide herbicides
EP1673357A2 (en) 2003-08-08 2006-06-28 Vertex Pharmaceuticals Incorporated Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain
AU2004285053B2 (en) * 2003-10-28 2010-10-21 Vertex Pharmaceuticals, Incorporated Benzimidazoles useful as modulators of ion channels
WO2006053227A2 (en) * 2004-11-10 2006-05-18 Synta Pharmaceuticals Corp. Il-12 modulatory compounds
DOP2006000210A (es) * 2005-10-04 2007-06-15 Aventis Pharma Inc Compuestos de pirimidina amida como inhibidores de pgds
JP5182088B2 (ja) * 2006-04-19 2013-04-10 アステラス製薬株式会社 アゾールカルボキサミド誘導体

Similar Documents

Publication Publication Date Title
JP2011500598A5 (https=)
JP2011500599A5 (https=)
JP2010539244A5 (https=)
RU2007111897A (ru) Хиназолины, полезные в качестве модуляторов ионных каналов перекрестные ссылки на родственные заявки
JP2011500600A5 (https=)
JP2011503112A5 (https=)
JP2010528035A5 (https=)
CN113423685B (zh) 整合应激通路的前药调节剂
ES2973442T3 (es) Moduladores de la vía integrada del estrés
JP2008511670A5 (https=)
RU2010118481A (ru) Амиды, применимые в качестве ингибиторов потенциалзависимых натриевых каналов
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
JP2014504642A5 (https=)
JP2019520417A5 (https=)
CN112218869A (zh) 整合应激通路的调节剂
JP2008545660A5 (https=)
JP2017517548A5 (https=)
JP2009539988A5 (https=)
JP2011503191A5 (https=)
JP2010528021A5 (https=)
UA124090C2 (uk) Інгібітори тирозинкінази
RU2007116858A (ru) Тиазолилдигидроиндазолы
CA2510534A1 (en) Compositions useful as inhibitors of protein kinases
JP2015503527A5 (https=)
JP2010509231A5 (https=)